Experience
İSTİNYE UNIVERSITY FACULTY OF MEDICINE
Liv Hospital
Liv Hospital Ulus
Acıbadem Bodrum Hospital
Tatvan State Hospital
Tatvan State Hospital
CLEVELAND CLINIC
Dokuz Eylul University Faculty of Medicine
Education
DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE, FACULTY OF MEDICINE/DEPARTMENT OF SURGICAL MEDICAL SCIENCES/DEPARTMENT OF GENERAL SURGERY
Dokuz Eylül University, General Surgery
AKDENİZ UNIVERSITY, FACULTY OF MEDICINE
Title: The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.
Title: Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer.
Title: The effect of fibrin glue in preventing staple-line leak after sleeve gastrectomy: an experimental study in rats.
Title: Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
Title: Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid–low rectal cancer.
Title: Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?
Title: Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A single-center experience.
Title: Predictive factors for conversion to open surgery in laparoscopic colorectal surgery.
Visite du médecin | prix sur demande |
Remplacement de la valvule cardiaque | $10000 - $15000 |
Chimiothérapie | |
Blépharoplastie (Correction des paupières) | $4000 |
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Lire la suite
Visite du médecin | prix sur demande |
Remplacement de la valvule cardiaque | $10000 - $15000 |
Chimiothérapie | |
Blépharoplastie (Correction des paupières) | $4000 |
Education
2002 Haydarpaşa Numune Training and Research Hospital, Internal Medicine
1990 Erciyes University, Faculty of Medicine
Experience
2019 - 2019 Okan University Hospital
2018 - 2019 Ibn Sina Hospital
2003 - 2018 Pendik State Hospital
1997 - 2003 Haydarpasa Numune Hospital
1990 - 1994 Erzincan State Hospital
Istanbul Haydarpasa Numune Hospital
Kartal Health Group Presidency
Yıldırım Beyazıt Mother and Child Health Physician
Lire la suite
Dr Ozates was born in 1966 in Birecik district of Sanliurfa in Turkey. He completed his primary and secondary education in my hometown, Birecik. He got into Istanbul University Istanbul Faculty of Medicine in 1983. After 6 years of successful education, he started Radiology education at Dicle University Faculty of Medicine by passing the Medical Specialization Examination (TUS) in the same year I graduated in 1989.
Between 1993 and 1995, he worked as a Radiology Specialist in various hospitals in Gaziantep. He passed the Assistant Professorship exam and started to work as a faculty member at Dicle University in 1995.
Post-Specialization Trainings:
2003, Gazi University Faculty of Medicine, MRI Department, Ankara
2003, Marmara University Faculty of Medicine, MRI Department, Istanbul
2001-2004, ESNR European Course of Neuroradiology (3 Semesters)
1997, Johns Hopkins University, Neuroradiology, Baltimore, USA
1997, Cornell University, Neuroradiology, New York, USA
1996, Istanbul University Faculty of Medicine, MRI Department, Istanbul
1994, Dokuz Eylül University Faculty of Medicine, MRI Department, İzmir
1993, Uludağ University Faculty of Medicine, MRI Department, Bursa
1993, UCLA Medical Center (as visitor), Los Angles, USA
1992-1993, Maçka EMAR, Dr. Murat Dinçer, Istanbul
His Academic Studies:
International Publications: 23
International Papers: 27
National Publications: 45
National Papers: 48
Conferences: 11
Citations: 210 Scientific Publications (Average Citations per Item: 10.50, h-index: 9), USA edition 1 Book, Various Conferences
Scientific Organizations he is a member of:
European Society of Radiology (ESR)
Turkish Radiology Association (TRD)
Magnetic Resonance Association
Istanbul Medical Chamber (ITO)
Turkish Neuroradiology Association
In 2003, he was awarded the title of Associate Professor with the examination held at Marmara University Faculty of Medicine. In 2005-2013, Dr. Lütfi Kırdar Kartal Training and Research Hospital Radiology Clinic Chief, Training and Administrative Officer.
In 2013, he started to work as a professor at Nişantaşı University. On March 15, 2013, he was appointed as the Inter-University Board Representative for 1 year. He is a Member of the Board of Trustees of Ayvansaray University. He is a sub – specialist in “Pediatric Radiology”
His articles have been published in many magazines in Turkey and abroad. He presented written and oral presentations and gave conferences at congresses in various cities and countries.
As the Radiology Clinic Chief of Bağcılar Training and Research Hospital, he is the first professor who performed Coronary CT Angiography in a state hospital in Istanbul.
He is one of Turkey’s first Children’s Radiology Specialist Minor. He did his military service between March and April 2000 at the 200-bed Malatya Military Hospital.
Lire la suiteLe Dr Ajith Kumar est un endocrinologue avec 18 ans d'expérience en tant que consultant. Il a commencé sa carrière en tant que résident principal en endocrinologie au PGIMER, Chandigarh. Après avoir obtenu un DM en endocrinologie, il a complété 15 années de pratique clinique. Il a été professeur adjoint au département d'endocrinologie des facultés de médecine associées à l'Université des sciences de la santé NTR pendant deux ans. Andhra Pradesh, Inde. Il a exercé les fonctions d'endocrinologue consultant pendant trois ans dans plusieurs hôpitaux multispécialisés du Kerala, en Inde. Il exerce comme endocrinologue à Dubaï depuis neuf ans.
Compétence
Diabète de type 2, diabète de type 1 et diabète pendant la grossesse (GDM)
Anomalies de la fonction thyroïdienne
Nodules thyroïdiens, gestion du cancer de la thyroïde et suivi
Troubles de l'hypophyse, y compris les tumeurs
Hypertension induite par les hormones
Troubles des glandes surrénales
Troubles de la croissance
Troubles de la puberté
SOPK et autres troubles ovariens
Troubles testiculaires
Obésité
Hyperlipidémie, hyperuricémie et autres conditions métaboliques
Ostéoporose, carence en vitamine D et autres troubles métaboliques osseux, y compris les anomalies parathyroïdiennes
Adhésion
Association américaine d'endocrinologie clinique (AACE)
La Société endocrinienne
Société endocrinienne de l'Inde et Société indienne de la thyroïde
Association indienne des médecins
Lire la suiteSpécialisation : Endocrinologie et Maladies Métaboliques
Langue étrangère : anglais
Éducation :
Faculté de médecine de l'Université Hacettepe / 1998
Formation de spécialisation ;
Faculté de médecine de l'Université Dokuz Eylül, Département des maladies internes /2004
Faculté de médecine de l'Université de Gazi, Département des maladies internes. Endocrinologie et maladies métaboliques BD. / 2012
Domaines d'expertise :
Diabète : Diabète
Application de la pompe à insuline
Syndrome métabolique : syndrome de résistance à l'insuline, obésité, hypertension, hyperglycémie
Obésité : surpoids
Chirurgie Bariatrique : Intervention chirurgicale pour excès de poids
Diabète gestationnel : taux élevé de sucre pendant la grossesse
Goitre : hypertrophie de la glande thyroïde
Hyperthyroïdie (goitre toxique) : glande thyroïde hyperactive
Hypothyroïdie : glande thyroïde sous-active
Thyroïdite : maladie inflammatoire de la glande thyroïde
Dysfonctionnement thyroïdien pendant la grossesse Maladies thyroïdiennes
avec des nodules
La maladie de Hashimoto
Cancers de la thyroïde
SOPK (syndrome des ovaires polykystiques) : aménorrhée, prise de poids et pousse des cheveux
Hirsutisme : pousse des cheveux
Ostéoporose : ostéoporose
Carence en vitamine D
Hypopitutarisme : insuffisance d'hormones hypophysaires
Prolactinome : excès de prolactine et d'hormone du lait
Maladie/syndrome de Cushing : excès d'hormone cortisol
Acromégalie : excès d’hormone de croissance
Gigantisme
Diabète insipide : miction excessive
Carence en hormone de croissance
Hauteur Court pour
Hyperparathyroïdie : excès de parathormone
Hypoparathyroïdie : déficit en hormone parathyroïdienne
Maladie d'Addison : déficit en hormone cortisol
Hyperaldostéronisme/syndrome de Conn : excès d'hormone aldostérone
Phéochromocytome : excès d'hormone catécholamine/adrénaline
Gynécomastie : hypertrophie mammaire chez l'homme
Hypogonadisme : déficit en hormone testostérone/manque de croissance testiculaire et pénienne et absence de barbe
Problèmes d'érection et impuissance
Hypercalcémie : excès de calcium Hypocalcémie : calcium
carence
Hyperlipidémie : cholestérol
Hypertriglycéridémie : taux élevé de lipides sanguins
Expérience:
Faculté de médecine de l'Université Afyon Kocatepe, Département des maladies internes.
Faculté de médecine de l'Université de Gazi, Département des maladies internes. Endocrinologie et maladies métaboliques BD.
Hôpital universitaire de formation et de recherche de Sakarya, Département des maladies internes. Endocrinologie et maladies métaboliques BD.
Hôpital Privé Medova / Konya
Le Dr. est titulaire d'un diplôme de médecine de la faculté de médecine de l'université d'Uludağ, Bursa, Turquie (1983), d'une bourse post-doctorale en thermoradiothérapie de l'université Thomas Jefferson, Philadelphie, Pennsylvanie (1990-1994), et d'une résidence en radio-oncologie du Centre d'oncologie et de médecine nucléaire d'Istanbul, Turquie (1990). Il a également occupé les postes de professeur, président et coordinateur de l'accréditation de la faculté au Collège médical de l'Université Uludağ (1991-2005), professeur et directeur au Centre médical Anadolu (2004-2017), et directeur à l'Hôpital international Ceylan et à l'Hôpital Medicana Bursa (2017-aujourd'hui).
Lire la suiteLe Dr X est un oncologue médical qui a plus de 30 ans d'expérience. Il est diplômé de l'Université d'Istanbul, spécialisé en médecine interne, et de l'Institut d'oncologie de l'Université d'Istanbul, spécialisé en oncologie médicale. Il est membre de l'Association d'oncologie médicale, de l'Association des cancers du poumon, de l'ESMO, de l'ASCO et de la Chambre médicale d'Istanbul.
Lire la suiteSpécialiste en oncologie médicale avec une expertise dans les cancers du poumon, du sein, colorectal, gastrique, du foie, du rein, du pancréas, de l'estomac, de la prostate et de l'utérus. Expérimenté en chimiothérapie, immunothérapie, phytothérapie, thérapie par l'ozone, chimiothérapie hyperthermique, cancer du SIG et cancer gynécologique et génito-urinaire. Membre du Turkish Oncology Group, de la Medical Oncology Association, de la Turkish Cancer Research and Warfare Association, de la Société européenne d'oncologie médicale, de la Société européenne d'oncologie gynécologique et de l'Association internationale pour l'étude du cancer du poumon.
Lire la suiteLe Dr. est chef d'équipe en endocrinologie chirurgicale à l'Université médicale de Vienne et spécialiste en chirurgie générale et viscérale. Il est titulaire d'un doctorat en médecine obtenu en 2005 et a occupé depuis lors divers postes, notamment ceux de professeur assistant, d'assistant de médecin, de professeur d'université, de médecin principal et de chef du groupe de travail sur l'endocrinologie chirurgicale. Il est membre de plusieurs sociétés et a reçu le Venia Docendi Award et le Sandoz Award for Thyroid Research.
Lire la suiteLe Dr Maksim Sazonov est un spécialiste de l'ON Clinic Kharkiv Gagarina et offre une expertise en chirurgie générale, endocrinologie et oncologie. Il est titulaire d'un doctorat en médecine et a plus de 25 ans d'expérience. Il est membre des associations ukrainienne et européenne de chirurgiens.
Lire la suite